摘要
随着中国药典2010年版将眼用制剂列入无菌制剂,眼用制剂的生产质量管理被提出了更高的要求。本文对目前眼用制剂生产现状进行分析,探讨眼用制剂生产与质量控制的关键风险点,并提出了一些风险控制策略,为企业提供参考。
Since ophthalmic preparations were defined as sterile preparation by Ch.P 2010, the requirement of production and qulity management of ophthalmic preparations is raised. The production status and the main risk points of the production and quality management of ophthalmic preparations are reviewed and discussed in this article as well as control strategies, aiming to provide some references to manufacturers.
出处
《中国现代应用药学》
CAS
CSCD
2015年第9期1144-1146,共3页
Chinese Journal of Modern Applied Pharmacy
关键词
眼用制剂
药品生产质量管理规范
风险分析
ophthalmic preparations
good manufacturing practice
risk analysis